Platelet Transfusion: And Update on Challenges and Outcomes
Open Access
- 1 January 2020
- journal article
- review article
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 11, 19-26
Abstract
Platelet transfusion is a common practice in onco-hematologic patients for preventing or treating hemorrhages. Platelet concentrates can be transfused with therapeutic or prophylactic purposes. With the aim to help clinicians to take the decisions on platelet transfusion, some guidelines have been developed based on the current scientific evidence. However, there are some controversial issues and available scientific evidence is not enough to solve them. There is little information about what is the best platelet product to be transfused: random platelets or single donor apheresis platelets, and plasma-suspended or additive solution suspended platelets. Platelets are often transfused without respecting the ABO compatibility, but influence of this practice on platelet transfusion outcome is not well established. In the prophylactic platelet transfusion set there are some questions unsolved as the platelet threshold to transfuse prior to specific procedures or surgery, and even if platelet transfusion is necessary for some specific procedures as autologous hematopoietic stem cell transplantation. A challenging complication raised from multiple platelet transfusions is the platelet transfusion refractoriness. The study and management of this complication is often disappointing. In summary, although it is a widespread practice, platelet transfusion has still many controversial and unknown issues. The objective of this article is to review the current evidence on platelet transfusion practices, focusing on the controversial issues and challenges.Keywords
This publication has 67 references indexed in Scilit:
- Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic reviewCochrane Database of Systematic Reviews, 2016
- Management of the Platelet Refractory PatientHematology/Oncology Clinics of North America, 2016
- Platelet refractoriness – practical approaches and ongoing dilemmas in patient managementBritish Journal of Haematology, 2015
- Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis componentsVox Sanguinis, 2013
- Platelet Transfusion - the Art and Science of CompromiseTransfusion Medicine and Hemotherapy, 2013
- ABO incompatible plateletsCurrent Opinion in Hematology, 2012
- ABO‐identical versus nonidentical platelet transfusion: a systematic reviewTransfusion, 2009
- Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methodsAsian Journal of Transfusion Science, 2009
- Single donor versus pooled random donor platelet concentratesCurrent Opinion in Hematology, 2001
- Blood group A and B antigens are strongly expressed on platelets of some individuals.2000